ANIK · Anika Therapeutics, Inc. · Investor Relations
One customer — 49% of revenue (nine-months ended September 30, 2026)
“Revenue from the Company’s sole significant customer, DePuy Synthes, formerly Johnson & Johnson MedTech, as a percentage of the Company’s total revenue was 47% and 51% for the three-months ended September 30, 2026, and 2025, respectively, and 49% and 50% for the nine-months ended September 30, 2026, and 2025, respectively.”
One customer — 47% of revenue (three-months ended September 30, 2026)
“Revenue from the Company’s sole significant customer, DePuy Synthes, formerly Johnson & Johnson MedTech, as a percentage of the Company’s total revenue was 47% and 51% for the three-months ended September 30, 2026, and 2025, respectively, and 49% and 50% for the nine-months ended September 30, 2026, and 2025, respectively.”
One customer — 51% of revenue (three-months ended September 30, 2025)
“Revenue from the Company’s sole significant customer, DePuy Synthes, formerly Johnson & Johnson MedTech, as a percentage of the Company’s total revenue was 47% and 51% for the three-months ended September 30, 2026, and 2025, respectively, and 49% and 50% for the nine-months ended September 30, 2026, and 2025, respectively.”
One customer — 50% of revenue (nine-months ended September 30, 2025)
“Revenue from the Company’s sole significant customer, DePuy Synthes, formerly Johnson & Johnson MedTech, as a percentage of the Company’s total revenue was 47% and 51% for the three-months ended September 30, 2026, and 2025, respectively, and 49% and 50% for the nine-months ended September 30, 2026, and 2025, respectively.”
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-06 | Q3 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-07-29 | Q2 2026 Anika Therapeutics Earnings Conference Call | Earnings call |
| 2026-04-29 | Q1 2026 Anika Therapeutics Earnings Conference Call | Earnings call |
| 2026-03-02 | Canaccord Genuity 2026 Musculoskeletal Conference | Conference |
| 2026-02-26 | Earnings conference call (announced in 8-K) | Earnings call |
| 2025-11-05 | Q3 2025 Anika Therapeutics Earnings Conference Call | Earnings call |
| 2025-07-30 | Q2 2025 Anika Therapeutics Earnings Conference Call | Earnings call |
| 2025-05-21 | Sidoti Virtual Investor Conference | Conference |
| 2025-05-09 | Q1 2025 Anika Therapeutics Earnings Conference Call | Earnings call |
| 2025-03-12 | Q4 2024 Anika Therapeutics Earnings Conference Call | Earnings call |
| 2025-03-10 | Canaccord Genuity 2025 Musculoskeletal Conference | Conference |
Source: https://ir.anika.com/